|
1
|
Akram M, Iqbal M, Daniyal M and Khan AU:
Awareness and current knowledge of breast cancer. Biol Res.
50:332017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leone BA, Vallejo CT, Romero AO,
Machiavelli MR, Pérez JE, Leone J and Leone JP: Prognostic impact
of metastatic pattern in stage IV breast cancer at initial
diagnosis. Breast Cancer Res Treat. 161:537–548. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen HS, Bai MH, Zhang T, Li GD and Liu M:
Ellagic acid induces cell cycle arrest and apoptosis through
TGF-β/Smad3 signaling pathway in human breast cancer MCF-7 cells.
Int J Oncol. 46:1730–1738. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lo PK, Zhang Y, Yao Y, Wolfson B, Yu J,
Han SY, Duru N and Zhou Q: Tumor-associated myoepithelial cells
promote the invasive progression of ductal carcinoma in situ
through activation of TGF β signaling. J Biol Chem.
292:11466–11484. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang KM, Kim W, Bae E, Gim J, Weist BM,
Jung Y, Hyun JS, Hernandez JB, Leem SH, Park T, et al: DRAK2
participates in a negative feedback loop to control TGF-β/Smads
signaling by binding to type I TGF-β receptor. Cell Rep.
2:1286–1299. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Massagué J: TGF β signaling in context.
Nat Rev Mol Cell Biol. 13:616–630. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ungefroren H, Groth S, Sebens S, Lehnert
H, Gieseler F and Fändrich F: Differential roles of Smad2 and Smad3
in the regulation of TGF-β1-mediated growth inhibition and cell
migration in pancreatic ductal adenocarcinoma cells: Control by
Rac1. Mol Cancer. 10:672011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu Y, Li Q, Zhou X, Yu J, Mu Y, Munker S,
Xu C, Shen Z, Müllenbach R, Liu Y, et al: Decreased levels of
active SMAD2 correlate with poor prognosis in gastric cancer. PLoS
One. 7:e356842012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Petersen M, Pardali E, van der Horst G,
Cheung H, van den Hoogen C, van der Pluijm G and Ten Dijke P: Smad2
and Smad3 have opposing roles in breast cancer bone metastasis by
differentially affecting tumor angiogenesis. Oncogene.
29:1351–1361. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan P, Klingbiel D, Saridaki Z, Ceppa P,
Curto M, McKee TA, Roth A, Tejpar S, Delorenzi M, Bosman FT and
Fiocca R: Reduced expression of SMAD4 is associated with poor
survival in colon cancer. Clin Cancer Res. 22:3037–3047. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamada S, Fujii T, Shimoyama Y, Kanda M,
Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Nakao A and
Kodera Y: SMAD4 expression predicts local spread and treatment
failure in resected pancreatic cancer. Pancreas. 44:660–664. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stuelten CH, Buck MB, Dippon J, Roberts
AB, Fritz P and Knabbe C: Smad4-Expression is decreased in breast
cancer tissues: A retrospective study. BMC Cancer. 6:252006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Q, Wu L, Oelschlager DK, Wan M,
Stockard CR, Grizzle WE, Wang N, Chen H, Sun Y and Cao X: Smad4
inhibits tumor growth by inducing apoptosis in estrogen
receptor-alpha-positive breast cancer cells. J Biol Chem.
280:27022–27028. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
So JY, Lee HJ, Kramata P, Minden A and Suh
N: Differential expression of key signaling proteins in MCF10 cell
lines, a human breast cancer progression model. Mol Cell Pharmacol.
4:31–40. 2012.PubMed/NCBI
|
|
15
|
Barroso-Sousa R and Metzger-Filho O:
Differences between invasive lobular and invasive ductal carcinoma
of the breast: Results and therapeutic implications. Ther Adv Med
Oncol. 8:261–266. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Taubert H, Heidenreich C, Holzhausen HJ,
Schulz A, Bache M, Kappler M, Eckert AW, Würl P, Melcher I,
Hauptmann K, et al: Expression of survivin detected by
immunohistochemistry in the cytoplasm and in the nucleus is
associated with prognosis of leiomyosarcoma and synovial sarcoma
patients. BMC Cancer. 10:652010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo K: Signaling cross talk between
TGF-β/Smad and other signaling pathways. Cold Spring Harb Perspect
Biol. 9:a0221372017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kretzschmar M: Transforming growth
factor-beta and breast cancer: Transforming growth factor-beta/SMAD
signaling defects and cancer. Breast Cancer Res. 2:107–115. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang Z, Li Z, Wang X, Kang Y, Yuan Y, Niu
J, Wang H, Chatterjee D, Fleming JB, Li M, et al: Deciphering the
mechanisms of tumorigenesis in human pancreatic ductal epithelial
cells. Clin Cancer Res. 19:549–559. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Caldarella A, Crocetti E, Bianchi S,
Vezzosi V, Urso C, Biancalani M and Zappa M: Female breast cancer
status according to ER, PR and HER2 expression: A population based
analysis. Pathol Oncol Res. 17:753–758. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen L, Zhong J, Liu JH, Liao DF, Shen YY,
Zhong XL, Xiao X, Ding WJ, Peng XD, Xiong W and Zu XY: Pokemon
inhibits transforming growth factor β-Smad4-related cell
proliferation arrest in breast cancer through specificity protein
1. J Breast Cancer. 22:15–28. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ying Z, Tian H, Li Y, Lian R, Li W, Wu S,
Zhang HZ, Wu J, Liu L, Song J, et al: CCT6A suppresses SMAD2 and
promotes prometastatic TGF-β signaling. J Clin Invest.
127:1725–1740. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang J, Wahdan-Alaswad R and Danielpour D:
Critical role of Smad2 in tumor suppression and transforming growth
factor-beta-induced apoptosis of prostate epithelial cells. Cancer
Res. 69:2185–2190. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hoot KE, Lighthall J, Han G, Lu SL, Li A,
Ju W, Kulesz-Martin M, Bottinger E and Wang XJ:
Keratinocyte-specific Smad2 ablation results in increased
epithelial-mesenchymal transition during skin cancer formation and
progression. J Clin Invest. 118:2722–2732. 2008.PubMed/NCBI
|
|
26
|
Hamamoto T, Beppu H, Okada H, Kawabata M,
Kitamura T, Miyazono K and Kato M: Compound disruption of smad2
accelerates malignant progression of intestinal tumors in apc
knockout mice. Cancer Res. 62:5955–5961. 2002.PubMed/NCBI
|
|
27
|
Zhao M, Mishra L and Deng CX: The role of
TGF-β/SMAD4 signaling in cancer. Int J Biol Sci. 14:111–123. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Voorneveld PW, Kodach LL, Jacobs RJ, Liv
N, Zonnevylle AC, Hoogenboom JP, Biemond I, Verspaget HW, Hommes
DW, de Rooij K, et al: Loss of SMAD4 alters BMP signaling to
promote colorectal cancer cell metastasis via activation of Rho and
ROCK. Gastroenterology. 147:196–208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ding Z, Wu CJ, Chu GC, Xiao Y, Ho D, Zhang
J, Perry SR, Labrot ES, Wu X, Lis R, et al: SMAD4-Dependent barrier
constrains prostate cancer growth and metastatic progression.
Nature. 470:269–273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu KJ, Zhu GF, Zhang D, Zeng J, Wang XY,
Xue Y, Zhang LL and He DL: Identification of TGF-beta/Smads pathway
in human prostate cancer cell lines and its significance. Zhonghua
Nan Ke Xue. 15:920–924. 2009.(In Chinese). PubMed/NCBI
|
|
31
|
Mhawech-Fauceglia P, Kesterson J, Wang D,
Akers S, DuPont NC, Clark K, Lele S and Liu S: Expression and
clinical significance of the transforming growth factor-β
signalling pathway in endometrial cancer. Histopathology. 59:63–72.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lv ZD, Kong B, Li JG, Qu HL, Wang XG, Cao
WH, Liu XY, Wang Y, Yang ZC, Xu HM and Wang HB: Transforming growth
factor-β 1 enhances the invasiveness of breast cancer cells by
inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Oncol Rep. 29:219–225. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie W, Mertens JC, Reiss DJ, Rimm DL, Camp
RL, Haffty BG and Reiss M: Alterations of Smad signaling in human
breast carcinoma are associated with poor outcome: A tissue
microarray study. Cancer Res. 62:497–505. 2002.PubMed/NCBI
|
|
34
|
Won KY, Kim YW and Park YK: Expression of
smad and its signalling cascade in osteosarcoma. Pathology.
42:242–247. 2010. View Article : Google Scholar : PubMed/NCBI
|
